Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-25 @ 8:23 PM
Study NCT ID:
NCT01926769
Status:
TERMINATED
Last Update Posted:
2018-05-15
First Post:
2013-08-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer
Sponsor:
Gachon University Gil Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2012-GIRBA-2675
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None